The short version
17 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Decitabine
decitabine · DECITABINE 50 mg/20mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Qilu Pharmaceutical Co., Ltd.
NDC 67184-0535-01 · 1 VIAL in 1 CARTON / 20 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $1,183.24 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA212826
- TE code
- AP
- Approval date
- Apr 12, 2021
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Decitabine, Injection, 50 mg (NDC 68001-573-41)Feb 20, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of decitabine (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 3, 2026 |
| Novadoz Pharmaceuticals LLC | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 3, 2026 |
| Accord Healthcare Inc. | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | DECITABINE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr.Reddy's Laboratories Limited | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | DECITABINE 50 mg/26mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | DECITABINE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC | DECITABINE 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | DECITABINE 50 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Decitabine — NDC 67184-0535-01," retrieved September 3, 2026, https://drugdashboards.com/drug/67184053501.
Free to cite with attribution — see how the data is put together.